BLFS 8-K 2026-10-06
BIOLIFE SOLUTIONS INC (BLFS) 8-K dated 2026-10-06 — accession 0001193125-26-415012.
BIOLIFE SOLUTIONS INC (BLFS) is a medical instruments & supplies company listed on US.
BIOLIFE SOLUTIONS INC filed a 8-K on 2026-10-06. Accession 0001193125-26-415012.
This 8-K covers: Acquisition or disposition (Item 2.01), Listing notice (Item 3.01), Change to holders' rights (Item 3.03), Change in control (Item 5.01), Director/officer change (Item 5.02), Bylaws or fiscal year change (Item 5.03). SEC EDGAR holds the official filing and its exhibits.
Latest reported BLFS revenue for 2025-12-31 was $96.2M. Net income was -$4.6M. Revenue was down 32.8% from 2023-12-31 to 2025-12-31. BLFS currently screens at market cap $1.05B.
Not investment advice. The BLFS SEC hub lists recent forms. The stock page is the research view.